Molecular basis of rifampin resistance in Mycobacterium leprae.
AUTOR(ES)
Honore, N
RESUMO
Rifampin is currently the most potent drug used in leprosy control programs. We show that the rifampin resistance which emerged in nine patients with lepromatous leprosy, who had received rifampin monotherapy, stemmed from mutations in the rpoB gene, which encodes the beta subunit of RNA polymerase of Mycobacterium leprae. In eight cases missense mutations were found to affect a serine residue, Ser-425, while in the remaining mutant a small insertion was found close to this site. These findings will be of use for the development of a rapid screening procedure, involving the polymerase chain reaction, for monitoring the emergence of rifampin-resistant M. leprae strains.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=187686Documentos Relacionados
- Molecular definition and identification of new proteins of Mycobacterium leprae.
- Molecular analysis of DNA and construction of genomic libraries of Mycobacterium leprae.
- Molecular Basis of Rifampin and Isoniazid Resistance in Mycobacterium bovis Strains Isolated in Sardinia, Italy
- Molecular Basis of Rifampin Resistance in Streptococcus pneumoniae
- Biophysical optima for metabolism of Mycobacterium leprae.